579 related articles for article (PubMed ID: 28438689)
1. Non-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets.
Klingenberg M; Matsuda A; Diederichs S; Patel T
J Hepatol; 2017 Sep; 67(3):603-618. PubMed ID: 28438689
[TBL] [Abstract][Full Text] [Related]
2. Non-coding RNA in drug resistance of hepatocellular carcinoma.
Ding B; Lou W; Xu L; Fan W
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30224380
[TBL] [Abstract][Full Text] [Related]
3. Role of non-coding RNAs in liver disease progression to hepatocellular carcinoma.
Heo MJ; Yun J; Kim SG
Arch Pharm Res; 2019 Jan; 42(1):48-62. PubMed ID: 30610616
[TBL] [Abstract][Full Text] [Related]
4. A long non-coding RNA lncRNA-PE promotes invasion and epithelial-mesenchymal transition in hepatocellular carcinoma through the miR-200a/b-ZEB1 pathway.
Shen Y; Liu S; Yuan H; Ying X; Fu H; Zheng X
Tumour Biol; 2017 May; 39(5):1010428317705756. PubMed ID: 28488544
[TBL] [Abstract][Full Text] [Related]
5. Biology and Clinical Application of Regulatory RNAs in Hepatocellular Carcinoma.
Pea A; Jamieson NB; Braconi C
Hepatology; 2021 Jan; 73 Suppl 1():38-48. PubMed ID: 32160335
[TBL] [Abstract][Full Text] [Related]
6. Let-7 inhibits self-renewal of hepatocellular cancer stem-like cells through regulating the epithelial-mesenchymal transition and the Wnt signaling pathway.
Jin B; Wang W; Meng XX; Du G; Li J; Zhang SZ; Zhou BH; Fu ZH
BMC Cancer; 2016 Nov; 16(1):863. PubMed ID: 27821157
[TBL] [Abstract][Full Text] [Related]
7. [CLINICAL SIGNIFICANCE OF NONCODING RNA IN HEPATOCELLULAR CARCINOMA].
Eguchi H; Doki Y; Mori M
Nihon Geka Gakkai Zasshi; 2015 Nov; 116(6):366-9. PubMed ID: 26845888
[TBL] [Abstract][Full Text] [Related]
8. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
Jin Y; Wang J; Han J; Luo D; Sun Z
Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma.
Wang YD; Sun XJ; Yin JJ; Yin M; Wang W; Nie ZQ; Xu J
Biomed Pharmacother; 2018 Oct; 106():134-141. PubMed ID: 29957463
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus X protein-mediated non-coding RNA aberrations in the development of human hepatocellular carcinoma.
Zhang B; Han S; Feng B; Chu X; Chen L; Wang R
Exp Mol Med; 2017 Feb; 49(2):e293. PubMed ID: 28186085
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinoma.
Qiu L; Tang Q; Li G; Chen K
Life Sci; 2017 Dec; 191():273-282. PubMed ID: 28987633
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal Stem Cells Promote Hepatocarcinogenesis via lncRNA-MUF Interaction with ANXA2 and miR-34a.
Yan X; Zhang D; Wu W; Wu S; Qian J; Hao Y; Yan F; Zhu P; Wu J; Huang G; Huang Y; Luo J; Liu X; Liu B; Chen X; Du Y; Chen R; Fan Z
Cancer Res; 2017 Dec; 77(23):6704-6716. PubMed ID: 28947421
[TBL] [Abstract][Full Text] [Related]
13. Inhibitions of epithelial to mesenchymal transition and cancer stem cells-like properties are involved in miR-148a-mediated anti-metastasis of hepatocellular carcinoma.
Yan H; Dong X; Zhong X; Ye J; Zhou Y; Yang X; Shen J; Zhang J
Mol Carcinog; 2014 Dec; 53(12):960-9. PubMed ID: 23861222
[TBL] [Abstract][Full Text] [Related]
14. Extracellular Vesicles as Delivery Vehicles for Non-Coding RNAs: Potential Biomarkers for Chronic Liver Diseases.
Ferro A; Saccu G; Mattivi S; Gaido A; Herrera Sanchez MB; Haque S; Silengo L; Altruda F; Durazzo M; Fagoonee S
Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540698
[TBL] [Abstract][Full Text] [Related]
15. Noncoding RNA as therapeutic targets for hepatocellular carcinoma.
George J; Patel T
Semin Liver Dis; 2015 Feb; 35(1):63-74. PubMed ID: 25632936
[TBL] [Abstract][Full Text] [Related]
16. Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications.
Wong CM; Tsang FH; Ng IO
Nat Rev Gastroenterol Hepatol; 2018 Mar; 15(3):137-151. PubMed ID: 29317776
[TBL] [Abstract][Full Text] [Related]
17. The emergence of long non-coding RNAs in the tumorigenesis of hepatocellular carcinoma.
Yang X; Xie X; Xiao YF; Xie R; Hu CJ; Tang B; Li BS; Yang SM
Cancer Lett; 2015 May; 360(2):119-24. PubMed ID: 25721084
[TBL] [Abstract][Full Text] [Related]
18. LINC01287/miR-298/STAT3 feedback loop regulates growth and the epithelial-to-mesenchymal transition phenotype in hepatocellular carcinoma cells.
Mo Y; He L; Lai Z; Wan Z; Chen Q; Pan S; Li L; Li D; Huang J; Xue F; Che S
J Exp Clin Cancer Res; 2018 Jul; 37(1):149. PubMed ID: 30001751
[TBL] [Abstract][Full Text] [Related]
19. Circular RNAs in hepatocellular carcinoma: Biomarkers, functions and mechanisms.
Qiu L; Xu H; Ji M; Shang D; Lu Z; Wu Y; Tu Z; Liu H
Life Sci; 2019 Aug; 231():116660. PubMed ID: 31319086
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]